Financial Data and Key Metrics Changes - The company reported Q1 revenue at $364.5 million, achieving the high end of its guidance range, despite a 3% negative foreign currency impact of $12.3 million [20] - GAAP earnings per share were $2.14, while adjusted earnings per share were $0.23, surpassing guidance and showing significant improvement over the prior year [20] - Q1 gross margin was 67.8%, down from 70.5% in the prior year, primarily due to revenue mix changes [20] - Selling expense as a percentage of revenue was 32.5%, a decline from the prior year, reflecting the overall revenue mix [21] - General and administrative expenses improved to 28.9% from 29.9%, indicating cost reduction efforts [22] Business Line Data and Key Metrics Changes - The core Nu Skin business gross margin was 76.7%, slightly down from the prior year but showing sequential improvement [20] - The RISE segments experienced 10% year-over-year growth in manufacturing, indicating strong performance in this area [7] - Latin America saw significant growth with a 144% year-on-year increase, driven by a focused developing market strategy [11] Market Data and Key Metrics Changes - Improving trends were noted in South Korea and China, while Europe and Africa showed better results due to an enhanced sales performance plan [6] - Southeast Asia Pacific markets experienced growth, although Indonesia faced additional headwinds [7] - Japan's performance remained stable on a local currency basis, contributing to a consistent consumer base [7] Company Strategy and Development Direction - The company outlined three strategic priorities for 2025: strengthening the core Nu Skin business, accelerating innovation with the IO intelligent beauty and wellness platform, and improving operational performance [8][9] - A major milestone was achieved with over $20 billion in sales compensation paid to the sales force, emphasizing the commitment to rewarding brand affiliates [10] - The company plans to enter the Indian market in mid-2026, leveraging a localized product suite and compensation plan [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's future despite macroeconomic pressures, highlighting strong partnerships with sales leaders [5] - The company is implementing proactive supply chain strategies to mitigate risks from global uncertainties, including tariffs [25] - Current projections suggest that tariffs are unlikely to materially impact costs in the near term, but consumer sentiment will be closely monitored [25] Other Important Information - The company reduced outstanding debt by $155 million, achieving the lowest debt level in over ten years [24] - Approximately $8 million was returned to shareholders through dividends and share repurchases [24] - The launch of the Prism IO intelligent wellness platform is anticipated to enhance customer relationships and drive revenue growth [13][17] Q&A Session Summary Question: What are the expectations for revenue in Q2? - The company projects second quarter revenue between $355 million and $390 million, factoring in an expected foreign currency headwind of 2% to 3% [26] Question: How is the company addressing macroeconomic pressures? - The company is implementing proactive supply chain strategies and closely monitoring potential effects on consumer sentiment and demand [25]

Financial Data and Key Metrics Changes - The company reported Q1 revenue of $364.5 million, achieving the high end of its guidance range, despite a 3% negative foreign currency impact of $12.3 million [17] - GAAP earnings per share (EPS) was $2.14, while adjusted EPS was $0.23, surpassing guidance and showing significant improvement over the prior year [17] - Q1 gross margin was 67.8%, down from 70.5% in the prior year, primarily due to revenue mix changes [17] - Selling expenses as a percentage of revenue decreased to 32.5%, reflecting a decline from the prior year [18] - General and administrative expenses improved to 28.9% of revenue, down from 29.9% [19] - The company reduced outstanding debt by $155 million, bringing total debt to $239 million, the lowest level in over ten years [21] Business Line Data and Key Metrics Changes - Significant growth was noted in Latin America, with a year-on-year growth of 144%, driven by a developing market strategy [5][9] - The core Nu Skin business gross margin was 76.7%, slightly down from the prior year but showing sequential improvement [17] - The RISE segments experienced 10% year-over-year growth in manufacturing [6] Market Data and Key Metrics Changes - Improving trends in key performance indicators (KPIs) were observed in South Korea and China, while Europe and Africa showed better results due to an enhanced sales performance plan [6] - Southeast Asia Pacific markets showed growth, although Indonesia faced additional headwinds [6] Company Strategy and Development Direction - The company outlined three strategic priorities for 2025: strengthening the core Nu Skin business, accelerating innovation related to the IO intelligent beauty and wellness platform, and improving operational performance and efficiency [7] - A major milestone was achieved with over $20 billion in sales compensation paid to the sales force, emphasizing the commitment to enhancing the sales compensation plan [8] - The company plans to enter the Indian market in Q4 2025, targeting a population of 1.4 billion with locally manufactured products [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's future despite near-term macroeconomic pressures, highlighting strong partnerships with sales leaders [4] - The company is implementing proactive supply chain strategies to mitigate risks from global uncertainties, including tariffs [22] - Guidance for Q2 revenue is projected between $355 million and $390 million, with anticipated foreign currency headwinds of 2% to 3% [23] Other Important Information - The introduction of Prism IO, an intelligent wellness platform, is expected to enhance customer relationships and product recommendations [11] - The company has amassed a significant antioxidant database, which will support the development of customized nutrition solutions [12][14] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.